bioRxiv/medRxiv TRiP Review Activity

413 Reviews — All Partners — Cancer Biology

Most recent first Previous |  Page 21: Articles 201-210  | Next

Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors
Iyer, S. R., Nusser, K., Jones, K., Shinde, P., Beach, C. Z., Keddy, C., Aguero, E., Force, J., Shinde, U., Davare, M. A.
10.1101/2022.12.27.521482 — Posted: 2022-12-27 — Discussion: 2023-09-02  EMBO Press
Intercellular Communication Compensates Intracellular Proliferative Signal Deficit during Liver Regeneration
Kaneko, K., Liang, Y., Liu, Q., Zhang, S., Song, D., Feng, G.-S.
10.1101/2022.05.16.492226 — Posted: 2023-02-08 — Discussion: 2023-08-29  eLife
Lipid Droplets Fuel Small Extracellular Vesicle Biogenesis
Genard, G., Tirinato, L., Pagliari, F., Da Silva, J., Giammona, A., Alquraish, F., Bordas, M., Marafioti, M. G., Di Franco, S., Jansen, J., Garcia-Calderon, D., Hanley, R., Nistico, C., Fukasawa, Y., Mueller, T., Krijgsveld, J., Todaro, M., Costanzo, F. S., Stassi, G., Nessling, M., Richter, K., Maass, K., Liberale, C., Seco, J.
10.1101/2022.10.24.513202 — Posted: 2022-10-24 — Discussion: 2023-08-29  Review Commons
NLRP3 controls ATM activation in response to DNA damage.
PETRILLI, V., Bodnar-Wachtel, M., Huber, A.-L., Gorry, J., Hacot, S., Gerossier, L., Guey, B., Goutagny, N., Bartosch, B., Ballot, E., Ghiringhelli, F., Py, B., Coute, Y., Ballesta, A., Lantuejoul, S., Hall, J.
10.1101/2020.05.12.087015 — Posted: 2020-05-14 — Discussion: 2023-08-26  EMBO Press
High-content microscopy reveals a morphological signature of bortezomib resistance
Kelley, M. E., Berman, A. Y., Stirling, D. R., Cimini, B. A., Han, Y., Singh, S., Carpenter, A. E., Kapoor, T. M., Way, G. P.
10.1101/2023.05.02.539137 — Posted: 2023-05-02 — Discussion: 2023-08-26  Review Commons
MYC disrupts transcriptional and metabolic circadian oscillations in cancer and promotes enhanced biosynthesis
DeRollo, R. E., Cazarin, J., Ahmad Shahidan, S. N. A. B., Burchett, J. B., Mwangi, D., Krishnaiah, S., Hsieh, A. L., Walton, Z. E., Brooks, R., Mello, S. S., Weljie, A. M., Dang, C. V., Altman, B. J.
10.1101/2023.01.03.522637 — Posted: 2023-01-03 — Discussion: 2023-08-25  Review Commons
Identifying targetable metabolic dependencies across colorectal cancer progression
Legge, D. N., Holt, A. K., Bull, C. J., Collard, T. J., Kollareddy, M., Bellamy, J., Groves, S., Ma, E. H., Hazelwood, E., Qualtrough, D., Amulic, B., Malik, K. N., Williams, A. C., Jones, N., Vincent, E. E.
10.1101/2022.03.23.485483 — Posted: 2022-03-23 — Discussion: 2023-08-23  Review Commons
Complementary CRISPR screen highlights the contrasting role of membrane-bound and soluble ICAM-1 in regulating antigen specific tumor cell killing by cytotoxic T cells
Mattes, A.-K., Puig Gamez, M., Martin, E., Boryn, L., Baskaran, P., Huber, H. J., Schuler, M., Park, J. E., Swee, L. K.
10.1101/2022.08.26.505456 — Posted: 2022-08-27 — Discussion: 2023-08-20  eLife
The BRD4S-LOXL2-MED1 interaction at the forefront of cell cycle transcriptional control in triple-negative breast cancer
Pascual-Reguant, L., Tian, T. V., Datta, D., Cianferoni, D., Kourtis, S., Ganez Zapater, A., Cannata, C., Serra Camprubi, Q., Espinar, L., Guirola, M., Querol, J., Miro Canturri, A., Arribas, J., Serrano, L., Peiro, S., Sdelci, S.
10.1101/2022.05.27.493725 — Posted: 2022-05-28 — Discussion: 2023-08-03  Review Commons
ATR inhibition augments the efficacy of lurbinectedin in small cell lung cancer
Schultz, C. W., Zhang, Y., Elmeskini, R., Zimmermann, A., Fu, H., Murai, Y., Wangsa, D., Kumar, S., Takahashi, N., Atkinson, D., Saha, L. K., Lee, C.-F., Elenbaas, B., Desai, P., Sebastian, R., Ried, T., Aladjem, M., Zenke, F. T., Weaver, Z., Pommier, Y., Thomas, A.
10.1101/2022.12.16.520783 — Posted: 2022-12-19 — Discussion: 2023-08-02  EMBO Press

Evaluation Sources